These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28287064)

  • 1. Concentrated ERP Delivered in a Group Setting: A Replication Study.
    Havnen A; Hansen B; Öst LG; Kvale G
    Behav Cogn Psychother; 2017 Sep; 45(5):530-536. PubMed ID: 28287064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
    JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder.
    Tjelle K; Opstad HB; Solem S; Kvale G; Wheaton MG; Björgvinsson T; Hansen B; Hagen K
    BMC Psychiatry; 2024 Apr; 24(1):327. PubMed ID: 38689256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disturbances in treatment-seeking OCD-patients: Changes after concentrated exposure treatment.
    Nordahl H; Havnen A; Hansen B; Öst LG; Kvale G
    Scand J Psychol; 2018 Apr; 59(2):186-191. PubMed ID: 29244201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting.
    Hansen B; Kvale G; Hagen K; Havnen A; Öst LG
    Cogn Behav Ther; 2019 Mar; 48(2):89-105. PubMed ID: 30088441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
    van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
    J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden gains in exposure therapy for obsessive-compulsive disorder.
    Collins LM; Coles ME
    Behav Res Ther; 2017 Jun; 93():1-5. PubMed ID: 28342401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dispositional resilience in treatment-seeking patients with obsessive-compulsive disorder and its association with treatment outcome.
    Holm SEH; Hansen B; Kvale G; Eilertsen T; Johnsen BH; Hystad SW; Solem S
    Scand J Psychol; 2019 Jun; 60(3):243-251. PubMed ID: 30841013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Phobie à deux" and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder.
    Moritz S; Külz A; Voderholzer U; Hillebrand T; McKay D; Jelinek L
    Cogn Behav Ther; 2019 Mar; 48(2):162-176. PubMed ID: 30064295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural group therapy for obsessive-compulsive disorder in Norway. An open community-based trial.
    Håland AT; Vogel PA; Lie B; Launes G; Pripp AH; Himle JA
    Behav Res Ther; 2010 Jun; 48(6):547-54. PubMed ID: 20359692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between Obsessive Compulsive Personality and Obsessive Compulsive Disorder Treatment Outcomes: Predictive Utility and Clinically Significant Change.
    Sadri SK; McEvoy PM; Egan SJ; Kane RT; Rees CS; Anderson RA
    Behav Cogn Psychother; 2017 Sep; 45(5):524-529. PubMed ID: 28390444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
    Xia J; Du Y; Han J; Liu G; Wang X
    Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protocol for a randomized controlled trial of exposure and response prevention for veterans with obsessive compulsive disorder.
    Ponzini GT; Hundt NE; Christie IC; Chen PV; Ecker AH; Lindsay JA; Teng EJ; Storch EA; Myers US; Roussev MS; Fletcher TL
    Contemp Clin Trials; 2024 Mar; 138():107445. PubMed ID: 38237674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and acceptability of the Bergen 4-day treatment for adolescents with OCD: a replication and extension.
    Skjold SH; Hagen K; Wheaton MG; Hjelle KM; Björgvinsson T; Hansen B
    BMC Psychiatry; 2024 Feb; 24(1):148. PubMed ID: 38383351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure and response prevention with or without parent management training for children with obsessive-compulsive disorder complicated by disruptive behavior: a multiple-baseline across-responses design study.
    Sukhodolsky DG; Gorman BS; Scahill L; Findley D; McGuire J
    J Anxiety Disord; 2013 Apr; 27(3):298-305. PubMed ID: 23602943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
    Reid AM; Garner LE; Van Kirk N; Gironda C; Krompinger JW; Brennan BP; Mathes BM; Monaghan SC; Tifft ED; André MC; Cattie J; Crosby JM; Elias JA
    Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. App-guided exposure and response prevention for obsessive compulsive disorder: an open pilot trial.
    Boisseau CL; Schwartzman CM; Lawton J; Mancebo MC
    Cogn Behav Ther; 2017 Nov; 46(6):447-458. PubMed ID: 28565937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled non-inferiority trial.
    Turner CM; Mataix-Cols D; Lovell K; Krebs G; Lang K; Byford S; Heyman I
    J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1298-1307.e2. PubMed ID: 25457928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing exposure and response prevention for OCD: a couple-based approach.
    Abramowitz JS; Baucom DH; Wheaton MG; Boeding S; Fabricant LE; Paprocki C; Fischer MS
    Behav Modif; 2013 Mar; 37(2):189-210. PubMed ID: 22619395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.